PHASQ — PhaseBio Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$3.73m
- $10.83m
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
PhaseBio Pharma slips on bankruptcy plans
Brief: PhaseBio Plans For Near-Term Sale Using Structured Process Through Chapter 11 Of U.S. Bankruptcy Code
U.S. RESEARCH ROUNDUP-Biogen, BTRS Holdings, Cintas
PhaseBio slumps as partner SFJ seeks transfer of blood pressure drug
U.S. RESEARCH ROUNDUP- PLx pharma, Vroom, Walmart
PhaseBio Pharmaceuticals Inc expected to post a loss of 31 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Brunswick, Hasbro, Seaworld Entertainment
Brief: Phasebio Pharmaceuticals Says Received A Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
U.S. RESEARCH ROUNDUP- Banner, Carmax, Labcorp
PhaseBio Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Deere & Co, Wix.com, Walmart
U.S. STOCKS ON THE MOVE-Nio Inc, Twilio Inc, Weber Inc
U.S. STOCKS ON THE MOVE-Cigna Corp, McDonald Corp, Nucor Corp
U.S. STOCKS ON THE MOVE-ShiftPixy Inc, Twitter Inc, Netflix Inc
PhaseBio plans to seek FDA approval for lead drug in Q4; shares surge
Brief: Phasebio Pharmaceuticals Reports Q1 Loss Of 23 Cents Per Share